Masitinib Plus Gemcitabine in Pancreatic Cancer

Clinical trial NCT03766295 · COMPLETED

Trial details

NCT number: NCT03766295
Sponsor: AB Science
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Pancreatic Cancer

Start date: 2014-07-01
Primary completion: 2020-12-01
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.